v3.23.3
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,226 $ 4,391
Short-term marketable securities 2,049
Prepaid expenses and other current assets 252 825
Deferred offering costs 41
Total assets 3,519 7,265
Current liabilities:    
Accounts payable 350 534
Accrued expenses 1,255 568
Total current liabilities 1,605 1,102
Common warrant liability 1,908
Total liabilities 3,513 1,102
Commitments and contingencies
Stockholders’ equity:    
Convertible preferred stock, $0.0001 par value; 15,000,000 shares authorized as of September 30, 2023, and December 31, 2022, respectively; no shares issued and outstanding at September 30, 2023, and December 31, 2022
Common stock, $0.0001 par value, 250,000,000 shares authorized at September 30, 2023, and December 31, 2022; 10,693,080 and 9,097,701 shares issued and outstanding as of September 30, 2023, and December 31, 2022, respectively 1 1
Additional paid-in capital 38,183 37,318
Accumulated other comprehensive income 17
Accumulated deficit (38,178) (31,173)
Total stockholders’ equity 6 6,163
Total liabilities and stockholders’ equity $ 3,519 $ 7,265

Source